Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) study

American Journal of Epidemiology

Volumn 144, Issue 11, 1996, Pages 1048-1057

  Szklo, Moyses ^a   Cerhan, James ^b   Diez Roux, Ana V ^a   Chambless, Lloyd ^c   Cooper, Lawton ^d   Folsom, Aaron R ^e   Fried, Linda P ^f   Knopman, David ^g   Nieto, F Javier ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c IL   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

Author keywords

cognition; cognition disorders; estrogen replacement therapy; menopause; women's health

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; COHORT ANALYSIS; COMMUNITY; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; HUMAN; INTELLIGENCE TEST; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; POSTMENOPAUSE; RISK FACTOR;

EID: 0029806643     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008877     Document Type: Article

References (46)

1. Amaducci LA, Fratiglione L, Rocca WA, et al. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 1986;36:922-31.
2. Bartus RT, Dean RL III, Beer B, et al. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217:408-17.
3. Broe GA, Henderson AS, Creasey H, et al. A case-control study of Alzheimer's disease in Australia. Neurology 1990; 40:1698-707.
4. Graves AB, White E, Koepsell TD, et al. A case-control study of Alzheimer's disease. Ann Neurol 1990;28:766-74.
5. Heyman A, Wilkinson WE, Stafford JA, et al. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984; 15:335-41.
6. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983;219: 1184-90.
7. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia - Alzheimer's type (SDAT). Psychoneuroendocrinology 1986;11:337-45.
8. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985;89:484-90.
9. Luine VN, McEwen BS. Sex differences in cholinergic enzymes of diagonal band nuclei in the rat preoptic area. Neuroendocrinology 1983;36:475-82.
10. Luine VN, Park D, Job T, et al. Immunochemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estradiol administration. Brain Res 1980; 191:273-7.
11. McEwen BS, Coirini H, Danielsson A, et al. Steroid and thyroid hormones modulate a changing brain. J Steroid Biochem Molec Biol 1991;40:1-14.
12. Toran-Allerand CD, Miranda RC, Bentham WDL, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci 1992;89:4668-72.
13. Miranda RC, Sohrabji F, Toran-Allerand CD. Interactions of estrogens with the neurotrophins and their receptors during neural development. Horm Behav 1994;28:367-75.
14. Fedor-Freybergh P. The influence of oestrogen on the well-being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynaecol Scand 1977;64:5-69.
15. Rauramo L, Langerspetz K, Engblom P, et al. The effect of castration and peroral estrogen therapy on some psychological functions. Front Horm Res 1975;8:133-51.
16. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-57.
17. Vanhulle G, Demol R. A double-blind study into the influence of estriol on a number of psychological tests in postmenopausal women. In: Van Keep PA, Greenblatt RB, Albeaux-Fernet M, eds. Consensus on menopausal research. Baltimore, MD: University Park Press, 1976:94-9.
18. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269:2637-41.
19. Brenner DE, Kukull WA, Stergachia A, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol 1994;140:262-7.
20. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994; 140: 256-61.
21. Ross RK, Paganini-Hill A, Mack TM, et al. Cardiovascular benefits of estrogen replacement therapy. Am J Obstet Gynecol 1989;160:1301-6.
22. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 1989;129:687-702.
23. Knopman DS, Ryberg S. A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Arch Neurol 1989;46:141-5.
24. Wechsler D. WAIS-R manual. Cleveland, OH: The Psychological Corporation, 1981.
25. Lezak MD. Neuropsychological assessment. 2nd ed. New York, NY: Oxford University Press, 1983:331-2.
26. Benton AL, Hamsher K. Multilingual aphasia examination. 2nd ed. Iowa City, IA: AJA Associates, 1989.
27. Tranel D. Neuropsychological assessment. Psychiatr Clin North Am 1992;15:283-99.
28. Benton AL, Eslinger PJ, Damasio AR. Normative observations on neuropsychological test performances in old age. J Clin Neuropsychol 1981;3:33-42.
29. Franzen MD. Multilingual aphasia examination. In: Keyser DJ, Sweetland RC, eds. Test critiques. Vol 5. Kansas City, MO: Test Corporation of America, 1986:278-82.
30. Baecke JA, Vurema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-42.
31. Appels A, Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur Heart J 1988;9:758-64.
32. Furuhjelm M, Fedor-Freybergh P. The influence of estrogens on the psyche in climacteric and post-menopausal women. In: Van Keep PA, Greenblatt RB, Albeaux-Fernet M, eds. Consensus on menopause research. Baltimore, MD: University Park Press, 1976:84-93.
33. Gerdes LC, Sonnendecker EW, Polakow ES. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women. Am J Obstet Gynecol 1982;142: 98-103.
34. Klaiber EL, Broverman DM, Vogel W, et al: Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979;36:550-4.
35. Kopera H. Estrogens and psychic functions. Fron Horm Res 1973;2:118-33.
36. Malleson J. An endocrine factor in certain affective disorders. Lancet 1953;2:158-64.
37. Matsumoto A, Arai Y. Neuronal plasticity in the deafferented hypothalamic arcuate nucleus of adult female rats and its enhancement by treatment with estrogen. J Comp Neurol 1981;197:197-206.
38. Frankfurt M, Gould E, Wooley C, et al. Gonadal steroids modify spine density in the ventromedial hypothalamus neurons: a Golgi study. Neuroendocrinology 1990;51:530-5.
39. Gould E, Wooley C, Frankfurt M, et al. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990;10:1286-91.
40. Eslinger PJ, Damasio AR, Benton AL, et al. Neuropsychological detection of abnormal mental decline in older persons. JAMA 1985;253:670-4.
41. Tranel D, Anderson SW, Benton AL. Development of the concept of "executive function" and its relationship to the frontal lobes. In: Boller F, Grafman J, eds. Handbook of neuropsychology. Vol 9. Amsterdam: Elsevier, 1988.
42. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-95.
43. Evans DA, Smith LA, Scherr PA, et al. Risk of death from Alzheimer's disease in a community population of older persons. Am J Epidemiol 1991;134:403-12.
44. Liu IY, LaCroix AZ, White LR, et al. Cognitive impairment and mortality: a study of possible confounders. Am J Epidemiol 1990;132:136-43.
45. Swan GE, Carmelli D, LaRue A. Performance on the digit symbol substitution test and 5-year mortality in the Western Collaborative Group Study. Am J Epidemiol 1995;141:32-40.
46. Deeg DJH, Hofman A, van Zonneveld RJ. The association between change in cognitive function and longevity in Dutch elderly. Am J Epidemiol 1990;132:973-82.